Marie Scherlund

Chief Program Officer at Oblique Therapeutics

Dr. Scherlund has extensive experience from the life science industry, from early development to product launch, working at both large and small size companies such as Astra Zeneca, RISE, APL, Moberg Pharma and Cadila Pharmaceuticals. Scherlund holds a Ph.D in Pharmaceutics from Uppsala University, and has wide-ranging leadership experience from different senior management positions, amongst project leadership, regulatory affairs as well as heading departments of pharmaceutical development and quality control.

Links

Previous companies

APL (Apotek Produktion & Laboratorier AB) logo
Moberg Pharma AB logo
RISE Research Institutes of Sweden logo
AstraZeneca logo

Org chart

Peers

Timeline

  • Chief Program Officer

    March, 2021 - present

View in org chart